Why the study?
Does levosimendan reduce worsening heart failure and death in patients with left ventricular failure due to an acute myocardial infarction?
Does levosimendan reduce worsening heart failure and death in patients with left ventricular failure due to an acute myocardial infarction?
Levosimendan is safe and reduces the risk of worsening heart failure and death in patients with left ventricular failure complicating acute myocardial infarction.
Supports levosimendan in acute MI with LV failure; extends RCT evidence to post-infarct decompensation.
s Levosimendan at doses 0.1-0.2 microg x kg(-1) x min(-1) did not induce hypotension or ischaemia and reduced the risk of worsening heart failure and death in patients with left ventricular failure complicating acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
V.S. Moiseyev (2002) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: